Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05160142
Other study ID # STUDY20190718
Secondary ID
Status Completed
Phase Early Phase 1
First received
Last updated
Start date September 5, 2019
Est. completion date November 21, 2019

Study information

Verified date December 2021
Source Case Western Reserve University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to assess the feasibility and efficacy of a community-based culinary nutrition education program (Diabetes Inspired Culinary Education, DICE) on improving the diabetes management and dietary intake of 6-14 year old children with type I diabetes mellitus (TIDM).


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date November 21, 2019
Est. primary completion date November 21, 2019
Accepts healthy volunteers No
Gender All
Age group 6 Years and older
Eligibility Inclusion Criteria: - Children: 6-14 years old; diagnosed with type I diabetes within the past 5 years; English speaking - Adults: primary caregiver of a 6-14 year old child diagnosed with type I diabetes within the past 5 years; English speaking Exclusion Criteria: -

Study Design


Intervention

Behavioral:
DICE
10-week culinary and nutrition education program for children with type I diabetes

Locations

Country Name City State
United States Dave's Grocery Store and Teaching Kitchen Cleveland Ohio

Sponsors (1)

Lead Sponsor Collaborator
Case Western Reserve University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary % Change in Hemoglobin A1c Blood glucose/diabetes management Baseline/pretest, 3 months/posttest
Secondary Change in daily servings of fruit Daily fruit intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool Baseline/pretest, 3 months/posttest
Secondary Change in daily servings of vegetables Daily vegetable intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool Baseline/pretest, 3 months/posttest
Secondary Change in daily servings of whole grains Daily whole grain intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool Baseline/pretest, 3 months/posttest
Secondary Change in daily servings of sugar-sweetened beverages Daily sugar-sweetened beverage intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool Baseline/pretest, 3 months/posttest
Secondary Change in daily total caloric intake Daily caloric intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool Baseline/pretest, 3 months/posttest
Secondary Change in primary caregiver body mass index (kg/m2) Assessment of weight status using calibrated stadiometer and electronic scale. Baseline/pretest, 3 months/posttest
Secondary Change in child body mass index z-score Assessment of weight status using calibrated stadiometer and electronic scale. Baseline/pretest, 3 months/posttest
Secondary Change in child blood pressure z-score Includes systolic and diastolic blood pressure z-scores Baseline, 3 months, 6 months, 9 months
Secondary Change in child food preparation attitude, self-efficacy and frequency of involvement Scale 0-132 (higher score indicates more positive attitude, higher self-efficacy, greater frequency of involvement) Baseline/pretest, 3 months/posttest
Secondary Change in child adherence to TIDM management regimen score Assessed via Diabetes Management Questionnaire - Scale of 14-70 (higher score indicating greater adherence to management regimen) Baseline/pretest, 3 months/posttest
Secondary Change in child quality of life score Assessed via Diabetes Quality of Life for Youth questionnaire - Scale of 41-205 (higher score indicating better quality of life) Baseline/pretest, 3 months/posttest
Secondary Change in primary caregiver self-efficacy for diabetes management score Assessed via Maternal Self-Efficacy for Diabetes Management Scale - Scale of 8-40 (higher score indicating greater self-efficacy for diabetes management) Baseline/pretest, 3 months/posttest
Secondary Change in primary caregiver self-efficacy for healthy meal planning and eating score Assessed via Parent Mealtime Self-Efficacy Questionnaire - Scale of 11-55 (higher score indicating greater self-efficacy for healthy meal planning and eating) Baseline/pretest, 3 months/posttest
See also
  Status Clinical Trial Phase
Withdrawn NCT05035368 - Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes Phase 2
Completed NCT01928329 - A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes Phase 2
Completed NCT02127762 - The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy N/A
Completed NCT00999375 - Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF) Phase 2
Completed NCT04279613 - A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Phase 1
Not yet recruiting NCT02117518 - Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients N/A
Withdrawn NCT01477476 - Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes Phase 2
Terminated NCT01308437 - Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics Phase 3
Terminated NCT01652911 - A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation Phase 1/Phase 2
Completed NCT06242548 - How Type I Diabetes Responds to Different Diets (Normoglucidic or Ketogenic) During Physical Activity at Altitude N/A
Completed NCT00351650 - Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan N/A
Withdrawn NCT00361608 - Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring Device N/A
Terminated NCT03653533 - Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin Pump N/A
Completed NCT00340639 - Management of Type 1 Diabetes Among Adolescents N/A
Completed NCT02002130 - The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes Phase 1
Completed NCT02634216 - Effects of Capros in Patients With Type-1 Diabetes N/A
Withdrawn NCT01623388 - Epigenetic Modifications of Diabetes Mellitus Type I N/A
Completed NCT02612493 - Obesity and Metabolic Surgery in Patients With Type I Diabetes N/A
Completed NCT01843114 - Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects N/A
Withdrawn NCT01398670 - Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics Phase 3